How much funding has Benevolent AI raised?

Benevolent AI has raised $205.0M in total funding, most recently a Series D round.

Who are Benevolent AI's investors?

Benevolent AI's investors include Temasek.

When was Benevolent AI founded?

Benevolent AI was founded in 2013.

Where is Benevolent AI headquartered?

Benevolent AI is headquartered in London, United Kingdom.

What industry is Benevolent AI in?

Benevolent AI operates in Artificial Intelligence, Biotech, Healthcare.

How many employees does Benevolent AI have?

Benevolent AI has 201-500 employees.

Benevolent AI

IPO

London, United Kingdom · Founded 2013 · $205.0M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: London
Employees: 201–500
Founded: 2013
Business Model: B2B

Website: benevolent.ai
Total Funding: $205.0M
Last Round: $90.0M Series DJan 2020
Rounds: 2

About

BenevolentAI is a UK-founded artificial intelligence drug discovery company established in 2013 and headquartered in London. The company combines advanced AI and machine learning with scientific expertise to accelerate drug discovery, build biomedical knowledge graphs, and identify novel therapeutic targets. BenevolentAI's proprietary platform ingests and reasons across vast biomedical literature and data to surface actionable insights for pharmaceutical researchers. The company has partnerships with major pharmaceutical companies and was publicly listed on Euronext Amsterdam before merging into Osaka Holdings in 2025.

Summary

Benevolent AI is an Artificial Intelligence company based in London, United Kingdom, founded in 2013. It has raised $205.0M in total across 2 rounds, most recently a $90.0M Series D round in Jan 2020. Investors include Temasek.

X (Twitter)